Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
The Daily Pilot’s e-newspaper includes Sunday’s coverage of Newport Beach, Huntington Beach, Costa Mesa, Laguna Beach, Fountain Valley and other parts of Orange County. The Daily Pilot’s e ...
As seven-time NASCAR Cup Series champion Jimmie Johnson attempts to lock his No. 84 Carvana Toyota Camry XSE into the field for the 2025 Daytona 500, he'll be c ...